Lori Kunkel, M.D.

Lori Kunkel, M.D.

DirectoratEnliven Therapeutics· In proxies 2023–2025

Lori Kunkel, M.D. sits on 8 public boards.

Boards1

  • Enliven TherapeuticsDirector · 1 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Enliven TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +178%
  2. ORIC Pharmaceuticals, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  3. K36 Therapeutics, Inc.Public company · 5 yr
    • Director2020 – 2025 · 5 yrNo stock prices for these years
  4. Nurix Therapeutics, Inc.Public company · 6 yr
    • Director2019 – 2025 · 6 yrNo stock prices for these years
  5. Curis, Inc.Public company · 6 yr
    • Director2016 – 2022 · 6 yrNo stock prices for these years
  6. Maverick Therapeutics, Inc.Public company · 4 yr
    • Director2017 – 2021 · 4 yrNo stock prices for these years
  7. Tocagen Inc.Public company · 5 yr
    • Director2015 – 2020 · 5 yrNo stock prices for these years
  8. Loxo Oncology, Inc.Public company · 5 yr
    • Director2014 – 2019 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?